Spider Rock Advisors, LLC Axsome Therapeutics, Inc. Transaction History
Spider Rock Advisors, LLC
- $6.17 Billion
- Q3 2024
A detailed history of Spider Rock Advisors, LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Spider Rock Advisors, LLC holds 65,008 shares of AXSM stock, worth $6.84 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
65,008
Previous 70,008
7.14%
Holding current value
$6.84 Million
Previous $5.64 Million
3.64%
% of portfolio
0.09%
Previous 0.11%
Shares
3 transactions
Others Institutions Holding AXSM
# of Institutions
398Shares Held
36.5MCall Options Held
751KPut Options Held
568K-
Vanguard Group Inc Valley Forge, PA3.95MShares$415 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$347 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY2.92MShares$308 Million5.58% of portfolio
-
Bvf Inc San Francisco, CA1.69MShares$178 Million8.66% of portfolio
-
Geode Capital Management, LLC Boston, MA989KShares$104 Million0.01% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $4.51B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...